Bimi International Medical Inc   (BIMI)
Other Ticker:  
Price: $1.3700 $0.00 0.000%
Day's High: $1.4399 Week Perf: 3.79 %
Day's Low: $ 1.31 30 Day Perf: 0.74 %
Volume (M): 31 52 Wk High: $ 4.13
Volume (M$): $ 42 52 Wk Avg: $1.98
Open: $1.39 52 Wk Low: $1.01

 Market Capitalization (Millions $) 9
 Shares Outstanding (Millions) 6
 Employees -
 Revenues (TTM) (Millions $) 18
 Net Income (TTM) (Millions $) -23
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Bimi International Medical Inc
Bimi International Medical Inc is a global medical technology company that focuses on providing innovative solutions in the healthcare industry. They specialize in developing diagnostic and therapeutic products that improve patient outcomes and quality of life. Bimi International Medical Inc serves a diverse range of medical specialties including cardiology, neurology, and oncology. Their dedication to research and development allows them to stay at the forefront of medical advancements and deliver cutting-edge solutions to healthcare professionals worldwide.

   Company Address: 725 5th Avenue New York 400010 NY
   Company Phone Number: 542 0028   Stock Exchange / Ticker: NASDAQ BIMI

Customers Net Income fell by BIMI's Customers Net Profit Margin fell to

-37.08 %

8.34 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
DHR        2.51% 
GPC        4.07% 
HON        1.64% 
MMM        2.91% 
RTX        1.18% 
• View Complete Report


BIMI Holdings Inc. Faces Delinquency Compliance Alert from Nasdaq: A Call to Swift and Transparent Action for Lasting Recovery.

Published Tue, Apr 23 2024 8:05 PM UTC

BIMI Holdings Inc. Faces Delinquency Compliance Alert Notice from Nasdaq: Implications and Path to RecoveryNew York, April 23, 2024 - BIMI Holdings Inc. (NASDAQ: BIMI) (BIMI or the Company), a leading healthcare products and services provider, recently announced that it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq St...

Bimi International Medical Inc

Bimi International Medical Inc Achieves Massive Revenue Growth of $2.5 Million in Q3 2023, Taking Stock Market by Storm

Bimi International Medical Inc is a promising company in the healthcare sector that has garnered attention in the stock market. In the fiscal interval closing September 30, 2023, the company witnessed a significant increase in revenue. However, the financial report also highlights some concerning aspects that must be investigated to understand the current performance and future prospects. This article aims to dissect the key facts and shed light on the potential implications for investors.
Revenue Growth and Net Deficit:
One of the noteworthy facts that caught investors' attention is Bimi International Medical Inc's revenue of $2.523193 million in the fiscal interval ending September 30, 2023. This indicates a positive trend and suggests the company is successfully generating income.

Bimi International Medical Inc

Bimi International Medical Inc Continues to Surge with Record Revenue of $5.5 Million in Q2 2023

Bimi International Medical Inc, a renowned medical company, has recently announced its impressive financial results for the fiscal period ending on June 30, 2023. The company generated a substantial revenue of $5.557666 million, which indicates a significant growth in its operations. Moreover, Bimi International Medical Inc also exhibited an improving profit margin, with a net margin of 18.97% and an operating margin of 23.38%.
One notable aspect of their financial statement is the decline in net earnings compared to the corresponding period the previous year. While Bimi International Medical Inc recorded no profits in the previous period, the company experienced a decline in net earnings, which amounted to $1.054 million in the current period. Although this decline might seem alarming at first, the company's overall performance and the growth in revenue indicate that Bimi International Medical Inc is still on a positive trajectory.

Bimi International Medical Inc

BIMI Reports Striking Revenue Slump Amidst Recent Fiscal Period, Raising Concerns Over Bimi International Medical Inc's Financial Position

BIMI Reports Disappointing Financial Results for Q1 2023: Future Performance Remains Uncertain
Bimi International Medical Inc (BIMI) recently disclosed its financial results for the interval ending March 31, 2023, which painted a disappointing picture for the company. Revenue experienced a significant decline of -36.299% to $3.20 million, while net loss per share reached $-0.23, as compared to $-0.27 in the first quarter of 2022.
This downturn stands in contrast to the remainder of the Pharmacy Services & Retail Drugstore sector, which saw a revenue improvement in the first quarter of 2023. In the previous reporting season, BIMI's EPS fell from $6.39 per share, while revenue turned positive from $-34,046.66 million.


Bimi International Medical Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com